Showing results (61-70 of 280) with videos related to
Sort By:
Pageof 28
World Journal of Gastroenterology|November 4, 2017
Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized personsAnders Boyd, Julie Bottero, Fabrice Carrat, et al.JAMA|November 9, 2017
Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel DiseaseMagali Lemaitre, Julien Kirchgesner, Annie Rudnichi, et al.Journal of Pediatric Gastroenterology and Nutrition|March 31, 2009
Diagnosis scoring for clinical identification of children with heterozygous familial hypercholesterolemiaPascale Benlian, Anne Turquet, Fabrice Carrat, et al.Plos One|July 16, 2016
Applications of Extreme Value Theory in Public HealthMaud Thomas, Magali Lemaitre, Mark L Wilson, et al.Vaccine|September 22, 2015
Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort studyRosemary Markovic Delabre, Nicolas Salez, Magali Lemaitre, et al.Gut|July 1, 2010
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapyHarry Sokol, Philippe Seksik, Fabrice Carrat, et al.Journal of Hepatology|March 4, 2008
Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02Patrice Cacoub, Fabrice Carrat, Pierre Bédossa, et al.Plos One|June 25, 2015
Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory InfectionsNicolas Salez, Astrid Vabret, Marianne Leruez-Ville, et al.BMC Public Health|December 22, 2010
Risk perception and priority setting for intervention among hepatitis C virus and environmental risks: a cross-sectional survey in the Cairo communityMichaël Schwarzinger, Mostafa K Mohamed, Rita R Gad, et al.Antiviral Therapy|May 12, 2009
Effect of antiviral treatment on serum markers of liver fibrosis in HIV-hepatitis C virus-coinfected patients: the Fibrovic 2 Study - ANRS HC02Philippe Halfon, Fabrice Carrat, Pierre Bédossa, et al.Pageof 28